等待開盤 08-01 09:30:00 美东时间
+0.080
+3.72%
今日重点评级关注:Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从6美元升至10美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从14美元升至14.5美元
06-12 11:32
Ascendiant Capital analyst Edward Woo maintains Aytu BioPharma (NASDAQ:AYTU) with a Buy and raises the price target from $14 to $14.5.
06-11 17:44
Aytu BioPharma (NASDAQ:AYTU) released third-quarter financial results and hoste...
05-14 05:39
Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.51) by 3.92 percent. This is a 352.38 percent decrease over earnings of $0.21 per share from
05-14 04:07
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
The earnings results for Aytu BioPharma (NASDAQ:AYTU) for Q2 were made public o...
02-04 05:58
Aytu BioPharma (NASDAQ:AYTU) released its Q2 earnings on Tuesday, February 3, 2...
02-04 05:08
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is expected to report ...
02-03 19:11